Find Academic Supervisors

Babette Bais is a researcher in the Department of Psychiatry at Erasmus MC, focusing on women's mental health, particularly during the preconception and prenatal periods. Her research integrates mobile health technologies and behavioral interventions to improve access to and uptake of preconception care, especially among women with vulnerable health statuses. Her research interests include prepregnancy care, mobile health (mHealth), mood and depressive disorders in pregnancy, bright light therapy, and psychoneuroendocrinology . She investigates how digital tools can support healthy lifestyle changes and mental well-being before and during pregnancy. The recent articles highlight a strong trend toward digital health interventions and clinical studies on depression during pregnancy . Her work combines randomized controlled trials, feasibility studies, and cohort designs to evaluate both biological markers (like cortisol) and behavioral outcomes. Key themes include the use of mobile apps for nudging behavior , light therapy for sleep and mood , and systemic evaluation of preconception care practices . Babette Bais has not been mentioned to have received any specific scientific awards in the provided text. She has contributed to supervised research work, as indicated by the 'Supervised Work (1)' metric, though no specific students are named. There is no mention of grant leadership or funding sources in the provided content. Her research is embedded within a collaborative network at Erasmus MC, particularly in psychiatric and perinatal health research, working closely with professionals in obstetrics, midwifery, and public health. The work is highly interdisciplinary, involving data from clinical trials, digital platforms, and population-level evaluations.

• Prepregnancy Care
• Mobile Health
• Mood Disorders
• +7 more

Daphne Voormolen is a researcher in the Department of Epidemiology at Erasmus MC, focusing on traumatic brain injury (TBI) and neurotrauma. She is actively involved in the CENTER-TBI consortium, contributing to large-scale, collaborative research aimed at improving clinical outcomes and understanding the epidemiology of TBI. Her research interests include traumatic brain injury, neurotrauma, intracranial pressure, intensive care unit management, cohort analysis, functional outcomes, mental health after injury, neuroimaging, and biomarker research. She applies epidemiological methods to clinical neuroscience problems, particularly in critical care settings. The recent publications highlight a strong focus on the clinical and imaging characteristics of TBI, dynamic treatment intensity, genetic vulnerabilities, and functional outcomes. The body of work demonstrates a multidisciplinary approach integrating clinical data, imaging, and molecular biomarkers to understand the full spectrum of TBI. Scientific Awards: No awards listed in the provided text. She has contributed to numerous collaborative studies and is likely involved in mentoring within large research teams, though no formal advisees are listed. Her work is supported by major international consortia such as CENTER-TBI and TRACK-TBI, reflecting significant grant funding and collaborative infrastructure. She does not appear to lead a standalone lab but is embedded within a large, multi-institutional research network focused on neurotrauma effectiveness.

• Traumatic Brain Injury
• Neurotrauma
• Epidemiology
• +11 more

Alexandra Zwiers is a researcher in the Department of Anesthesiology at Erasmus MC, Rotterdam. Her work focuses on pediatric anesthesia and acute kidney injury in neonates and critically ill children. She has contributed significantly to the understanding of renal biomarkers and their clinical application in pediatric populations. Research Interests: Her primary research areas include pediatric anesthesiology, neonatal critical care, acute kidney injury, and the development and validation of biomarkers such as NGAL, IL-18, and proenkephalin. She investigates perioperative care in preterm infants, particularly those undergoing surgery for necrotizing enterocolitis. Publication Trends: Her recent publications (2015–2024) show a consistent focus on renal injury biomarkers in pediatric populations, with an emphasis on clinical validation and reference value establishment. The work spans anesthesia practice surveys, biomarker performance studies, and translational research in kidney transplantation and critical illness. Thesis: PhD Thesis: Do not squeeze the kidneys! Acute kidney injury in critically ill children (2015, Erasmus Universiteit Rotterdam) Scientific Contributions: While no formal awards are listed, her research has been cited over 30 times and picked up by 20 news outlets, indicating significant impact in the medical community. Collaborations: She has collaborated with researchers across Erasmus MC in nephrology, critical care, and clinical chemistry. Her network includes experts in pediatric transplantation, pharmacology, and neonatology, reflecting interdisciplinary research engagement. Laboratories and Teams: Although specific labs are not named, her work is embedded within the clinical and research infrastructure of Erasmus MC’s Department of Anesthesiology and likely involves collaboration with the pediatric intensive care and nephrology units.

• Pediatric Anesthesiology
• Neonatal Critical Care
• Acute Kidney Injury
• +5 more

Dr. Maarten Leening, MD MSc PhD, is a researcher at Erasmus MC, with affiliations in the departments of Cardiology, Epidemiology, and Radiology & Nuclear Medicine. His work bridges clinical cardiology and population health, focusing on improving cardiovascular risk prediction and prevention strategies. His research interests center on cardiovascular disease epidemiology , particularly atherosclerotic heart disease, coronary and aortic valve calcification, and the use of biomarkers like lipoprotein(a) and NT-proBNP for risk stratification. He is deeply involved in refining primary prevention guidelines using imaging and biochemical markers. The most recent articles highlight a strong trend in cardiovascular risk refinement , combining imaging (e.g., coronary artery calcium scoring) with biomarkers to guide statin use and improve preventive care. His work also extends to methodological issues in clinical research and the health of vulnerable populations, such as older adults with intellectual disabilities. Dr. Leening has contributed to high-impact journals including Circulation , JACC: Cardiovascular Imaging , and the European Journal of Epidemiology . He has supervised at least one doctoral thesis, indicating active mentorship. His research network shows collaborations across epidemiology, radiology, and cardiology, reflecting a multidisciplinary approach. No scientific awards are listed in the provided text. He is part of the Erasmus MC research community, contributing to large-scale population studies and clinical guideline development, with ongoing work in risk prediction models and trial methodology.

• Cardiovascular Disease
• Atherosclerotic Heart Disease
• Cardiovascular Risk Assessment
• +12 more

Shahzad Ahmad is a Researcher in the Department of Epidemiology at Erasmus MC, focusing on the genetic and molecular underpinnings of neurodegenerative diseases, particularly Alzheimer’s disease. His research leverages large-scale genomic approaches including genome-wide association studies (GWAS), exome sequencing, and meta-analyses to identify biomarkers and genetic risk factors. His research interests span Genetics, Molecular Biology, Biochemistry, and Neuroscience , with specific emphasis on neurofilament light (NfL), tau protein, oxidative stress, inflammatory metabolites, and blood plasma biomarkers . He actively contributes to major international consortia such as EADB, CHARGE, and ADGC, indicating strong collaborative networks in the field of neuroepidemiology. The most recent articles highlight a trend toward integrating multi-omics data—genomics, proteomics, and metabolomics—to understand neurodegeneration. His work frequently explores quantitative trait loci, Mendelian randomization, and population-level variation in biomarkers, aiming to uncover mechanisms linking metabolism and brain health. While no scientific awards are listed in the provided text, his publications in high-impact journals such as Molecular Psychiatry , Nature Human Behaviour , and Communications Biology reflect significant scholarly contributions. There is no mention of student advising or grant funding in the available data. However, given his central role in multiple large-scale studies, it is likely he participates in collaborative research teams and projects involving data analysis, biomarker discovery, and genetic epidemiology.

• Genetics
• Genome-Wide Association Study
• Exome Sequencing
• +15 more

Tom de Leeuw is a MD Researcher in the Department of Anesthesiology at Erasmus MC, Rotterdam, specializing in pediatric pain conditions and anesthesia-related research. His work bridges clinical practice and academic investigation within the medical center's pain research ecosystem. His research focuses on Pediatric pain mechanisms , Chronic pain management in children , and Developmental anesthesia considerations , with strong emphasis on the biopsychosocial model . He investigates pharmacological interventions (Morphine, Gabapentin, Paracetamol), pain sensitivity biomarkers, and non-pharmacological approaches, particularly addressing vulnerable populations like maltreated adolescents. Analysis of his 2023-2025 publications reveals three dominant trends: (1) Post-surgical pain trajectories in adolescents (e.g., scoliosis), (2) Intersections between childhood trauma and pain processing, and (3) Clinical application of biopsychosocial frameworks for nerve entrapment syndromes. His methodology favors prospective cohort studies and scoping reviews, with growing emphasis on quantitative sensory testing and multidisciplinary treatment protocols.

• Pediatric pain
• Pediatric chronic pain
• Pediatric anesthesia
• +3 more

Kristin Mol is a researcher in the Department of Anesthesiology at Erasmus MC, Rotterdam, focusing on perioperative cardiovascular risk assessment and outcomes in noncardiac surgery. Her work integrates clinical data, biomarkers, and long-term patient follow-up to improve risk stratification and postoperative care. Her research interests lie at the intersection of anesthesiology and cardiology, particularly in evaluating myocardial injury after noncardiac surgery (MINS) , the role of high-sensitivity troponin T , and the impact of intraoperative and postoperative hypotension . She employs prospective cohort studies and matched cohort analyses to investigate how physiological stressors during surgery influence long-term health outcomes and quality of life. The trends in her publications show a consistent focus on clinical translation, with studies published in top-tier journals such as Anesthesiology and British Journal of Anaesthesia . Her work often involves collaborations with experts in anesthesiology, cardiology, and vascular surgery, emphasizing multidisciplinary approaches to perioperative medicine. Scientific Awards: No scientific awards mentioned in the provided text. Kristin Mol has contributed to significant research projects related to cardiac risk in surgical patients, potentially supported by institutional or national grants in perioperative medicine, though specific funding sources are not listed. She has collaborated extensively with senior researchers such as Svenja E. Hoeks, Robert J. Stolker, and Fenneke van Lier. While no formal advisees are listed, her recent completion of a doctoral thesis suggests she is in a postdoctoral or early independent research phase. There is no mention of leadership in labs or research teams in the provided information.

• Anesthesiology
• Perioperative Medicine
• Cardiac Risk Assessment
• +7 more

Reno Debets is a Full Professor in the Department of Medical Oncology at Erasmus MC, a leading academic medical center in the Netherlands. His research is centered on advancing cancer immunotherapy through deep investigation of T cell biology and tumor immunology. His research interests include T cell biology , immune checkpoints , cytotoxic T-cells , and tumor microenvironment dynamics . He investigates how T cells interact with cancer cells, particularly in glioblastoma and urothelial cancers, aiming to overcome immune evasion mechanisms. His work integrates molecular oncology with immunological analysis to develop novel therapeutic strategies. The recent trend in his publications shows a strong focus on immune modulation in solid tumors , biomarker discovery , and nanoparticle-based drug delivery , with contributions to high-impact journals such as Nature Communications and Cancer Research . He has supervised 10 research projects, indicating an active role in mentoring the next generation of scientists. Although no specific awards are listed, his extensive publication record and leadership in collaborative research underscore his scientific impact. Reno Debets is part of a dynamic research network at Erasmus MC, working closely with teams in oncology, immunology, and molecular diagnostics. His lab appears to focus on translational immunology, bridging basic science with clinical applications in cancer therapy.

• T Cell Biology
• Immune Checkpoints
• Cancer Immunotherapy
• +7 more

Joany Zachariasse is a Researcher in the Department of Pediatrics at Erasmus MC, Netherlands. Her work is centered on pediatric emergency medicine, with a focus on improving risk assessment and triage processes for febrile children in emergency departments across Europe and in low- and middle-income countries. Research Interests: Dr. Zachariasse's research spans critical areas in pediatric emergency care, including the use of biomarkers such as procalcitonin and white blood cell count to predict serious bacterial infections and sepsis in children. She actively investigates clinical decision-making tools like the Emergency Department-Paediatric Early Warning Score (ED-PEWS) and fast-track systems for low-urgent cases. Her work emphasizes evidence-based, multicenter observational studies to optimize real-life management of febrile children. Recent Research Trends: Analysis of her recent publications reveals a strong trend toward large-scale, collaborative European research initiatives such as the PERFORM and VITaLs consortia. Her studies predominantly employ observational methodologies to assess diagnostic accuracy, triage efficiency, and emergency service utilization. The integration of vital signs, laboratory markers, and clinical scoring systems in diverse healthcare settings is a recurring theme. Scientific Awards: No awards mentioned in the provided text. Advising and Grants: There is no explicit information about students or grants advised by Dr. Zachariasse in the provided text. However, her leadership roles in multicenter studies such as those under the PERFORM and VITaLs consortia suggest significant collaborative research activity, likely involving grant funding and team coordination. She frequently collaborates with senior researchers like H.A. Moll and participates in international networks, indicating an influential role in shaping pediatric emergency guidelines. Labs and Teams: Dr. Zachariasse is actively involved in major research consortia including the PERFORM consortium (Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union) and the VITaLs study group (VItal signs and Triage in Low- and middle income countries). These collaborations involve institutions across Europe and focus on generating high-impact, generalizable evidence for pediatric emergency care.

• Pediatrics
• Emergency Medicine
• Triage
• +12 more

Pieter Sonneveld is a Professor and active researcher in the Department of Hematology at Erasmus MC, a leading academic medical center in the Netherlands. His work is central to advancing the understanding and treatment of multiple myeloma through clinical and translational research. Institution: Erasmus MC Department: Hematology Academic Rank: Professor His research focuses on multiple myeloma, with particular emphasis on treatment outcomes, minimal residual disease (MRD), and novel therapeutic agents such as daratumumab, lenalidomide, and pomalidomide. He investigates prognostic factors including cytogenetic abnormalities and the International Staging System, aiming to improve risk stratification and personalized therapy. His work integrates clinical trial data with molecular and immunological insights to understand disease progression and treatment response. The recent publications highlight a strong trend in using pooled clinical trial data, MRD dynamics, and animal models to refine endpoints and explore curative strategies in myeloma. His studies frequently appear in high-impact journals such as the Journal of Clinical Oncology and Blood Cancer Journal , reflecting significant influence in the field. Pieter Sonneveld has been involved in numerous clinical trials and collaborative research networks, contributing to pivotal advancements in myeloma therapy. While specific grants are not listed, his leadership in large-scale studies suggests substantial research funding and international collaboration. He has supervised 23 research projects, indicating active mentorship of junior researchers and students, although individual names are not disclosed. He is not associated with any named laboratory or research team in the provided text, but his collaborative network spans multiple institutions and countries.

• Multiple Myeloma
• Hematology
• Oncology
• +12 more

Dr. Janine Felix is an Associate Professor in the Department of Pediatrics at Erasmus MC, Erasmus School of Medicine. Her research is centered on the epigenetic and genetic mechanisms underlying early-life determinants of child health and development. She is actively involved in large-scale international collaborations and cohort studies focusing on prenatal exposures, epigenetics, and long-term child outcomes. Her research interests span epigenetics , DNA methylation , genetics , perinatal epidemiology , and developmental origins of health and disease . She investigates how maternal factors such as diet, stress, and asthma influence offspring through epigenetic modifications, particularly in neonates. Her work also explores the biological pathways linking early adversity to multimorbidity and psychiatric symptoms using advanced methods like Mendelian randomization. The recent trend in her publications shows a strong emphasis on epigenome-wide association studies (EWAS) , trans-ancestry genomics , and prospective cohort analyses . Her work integrates genetic, epigenetic, and environmental data to understand child cognitive development, body composition, and mental health. She frequently publishes in high-impact journals such as Clinical Epigenetics , PLoS Medicine , and Brain, Behavior, and Immunity . DNA Methylation Epigenome Offspring Genetics Epigenetics Genome-Wide Association Study Dr. Felix has supervised at least four research projects, indicating her role in mentoring the next generation of scientists. While specific grants are not listed, her involvement in multi-cohort, international studies suggests leadership in collaborative research initiatives. She has contributed to significant datasets, including one on prenatal maternal stress and neonatal epigenetics, which has been widely accessed and cited. She is a key contributor to large consortia and collaborative networks, working with researchers across Europe and beyond. Her work is highly interdisciplinary, bridging pediatrics, genetics, epidemiology, and neuroscience.

• Epigenetics
• DNA Methylation
• Genetics
• +12 more

Jorn Assmann is a researcher in the Department of Immunology at Erasmus MC, Rotterdam. His work focuses on molecular and functional aspects of lymphocyte biology, particularly in the context of chronic lymphocytic leukemia (CLL) and T-cell large granular lymphocyte leukemia. He employs advanced techniques such as high-throughput proteomics and next-generation sequencing to identify biomarkers and understand immune dysregulation. His research interests include: T-cell receptor repertoire dynamics Minimal residual disease detection in CLL Proteomic biomarker discovery STAT3 signaling in lymphoproliferative disorders Immune cell signaling and regulation Molecular mechanisms of T-cell leukemias The recent publications show a strong trend toward integrating proteomic and genomic data to improve prognostic stratification in hematological malignancies. His work frequently involves collaborative, multi-center studies and has been published in high-impact journals such as Blood and HemaSphere . Jorn Assmann has not received any explicitly mentioned scientific awards in the provided text. He has contributed significantly to research in immunology and hematological cancers, particularly through biomarker discovery and functional characterization of lymphocyte disorders. While no formal advising roles are mentioned, his involvement in doctoral research suggests mentorship within a collaborative team environment. His research is supported through institutional affiliations and collaborative networks at Erasmus MC. His work is embedded within the immunology research group at Erasmus MC, which focuses on translational immunology, lymphocyte signaling, and molecular diagnostics in hematological diseases.

• Immunology
• T Cell Biology
• Chronic Lymphocytic Leukemia (CLL)
• +12 more

Ke-xin Wen is a Researcher in the Department of Clinical Genetics at Erasmus MC, a leading medical center affiliated with Erasmus University Rotterdam. Their work spans multiple disciplines including immunology, genetics, and neurology, with a particular focus on migraine research and autoimmune diseases. Dr. Wen's research interests primarily focus on the intersection of immunology and neurology. Their work examines how genetic factors influence neurological conditions, particularly migraines, and how immune responses contribute to vascular and neurological disorders. They have made significant contributions to understanding the role of dendritic cells and Th17 cells in autoimmune conditions, as well as investigating genetic variants that affect cerebral blood flow and vascular health in migraine patients. The research fingerprint shows strong engagement with Berylliosis (100%), Tertiary Lymphoid Structure (100%), Th17 Cell (100%), and Dendritic Cell (100%) research areas. The publication portfolio demonstrates a consistent interdisciplinary approach connecting genetics, immunology, and neurology. Recent work has expanded into large-scale genetic studies and metabolomics approaches to understand migraine pathophysiology. Dr. Wen's articles reveal a progression from cellular and animal model research toward population-level studies examining vascular components of neurological disorders. Dr. Wen has been actively involved in major collaborative research initiatives, including the Rotterdam Study, a prospective cohort study ongoing since 1990 in Rotterdam, Netherlands. Their work often involves large-scale data analysis and international research collaborations across multiple institutions, as evidenced by their contribution to the Nature Communications paper analyzing data from over 300,000 individuals.

• Immunology
• Genetics
• Neurology
• +4 more

J.I. Roodnat is a Researcher in the Department of Internal Medicine at Erasmus MC, a leading medical university center in the Netherlands. The research focuses on kidney transplantation, graft survival, and metabolic complications in renal disease, with a strong emphasis on clinical and translational outcomes. Research Interests: Roodnat's work centers on improving outcomes in kidney transplantation, particularly through understanding the impact of oxalic acid, residual diuresis, and HLA antibody profiles. Research spans immunosuppressive strategies, desensitization protocols, and long-term function in both recipients and living donors. Key topics include graft failure prediction, therapeutic drug monitoring, and metabolic nephrology. The recent publications indicate a strong trend in clinical and metabolic research in transplantation, particularly focusing on modifiable factors affecting graft survival and donor safety. Studies integrate biochemical markers, clinical parameters, and immunological profiling to optimize transplant outcomes. Collaborations and Supervision: Roodnat actively collaborates with multidisciplinary teams at Erasmus MC, including nephrologists, immunologists, and clinical chemists. The researcher has contributed to supervised academic work, including doctoral theses and peer-reviewed publications, reflecting a role in mentoring and academic guidance. While no formal grants are listed, the volume and quality of research suggest involvement in funded projects within the transplant program. Laboratory and Research Group: Work is conducted within the transplant research unit at Erasmus MC, which specializes in clinical transplantation studies, biomarker discovery, and immunological monitoring. The team is part of a larger network focused on improving solid organ transplantation outcomes through evidence-based strategies.

• Kidney Transplantation
• Graft Survival
• Living Donor Transplantation
• +7 more

Robert Zietse is a Full Professor in the Department of Internal Medicine at Erasmus MC, a prominent academic medical center in the Netherlands. His work spans clinical research, patient care, and academic leadership in nephrology and transplantation medicine. His primary research interests include kidney transplantation , graft survival , polycystic kidney disease , hyponatremia , and electrolyte imbalances . He has also contributed to interdisciplinary research on bio-artificial pancreas therapy for type 1 diabetes, exploring both clinical and societal perspectives. The recent publications show a strong trend toward biomarker discovery, predictive modeling of kidney disease progression, and translational research bridging laboratory findings with clinical implementation. His work frequently appears in high-impact journals such as PLoS ONE , Clinical Journal of the American Society of Nephrology , and Transplantation Direct . He has supervised 19 research projects, indicating an active role in mentoring junior researchers and medical students, although specific names of advisees are not listed. Collaborations include the VANGUARD consortium and multiple clinical departments at Erasmus MC, reflecting a networked, team-based approach to complex medical challenges.

• Nephrology
• Kidney Transplantation
• Graft Survival
• +7 more